Sat, Nov 9, 2024
Instructions for Authors
Journal of Pediatrics Review (JPR) is an international, quarterly, peer reviewed and open access and ISI [Web of Science Emerging Sources Citation Index (ESCI)] indexed journal compiled by Mazandaran University of Medical Sciences, Sari, Iran that publishes papers mainly focused on Review Articles and only one original article per issue in all fields of paediatrics including but not limited to the following fields: Adolescent Medicine, Developmental Pediatrics, and Medical genetics, Neonatology, Pediatric Allergology, Pediatric Cardiology, Pediatric Dermatology, Pediatric Endocrinology, Pediatric Gastroenterology, Pediatric Hematology and Oncology, Pediatric Infectious Diseases, Pediatric Intensive Care, Pediatric Nephrology, Pediatric Neurology, Pediatric Respirology, Pediatric Rheumatology, Pediatric Surgery.
Submission procedures
Manuscripts must be submitted only via online submission. Once you have prepared your manuscript according to the instructions below. Please visit the online submission web site. http://jpediatricsreview.com/en/index.html
Types of Articles
Journal of Pediatrics Review welcomes just the following types of submissions:
Journal of Pediatrics Review (JPR) is an international, quarterly, peer reviewed and open access and ISI [Web of Science Emerging Sources Citation Index (ESCI)] indexed journal compiled by Mazandaran University of Medical Sciences, Sari, Iran that publishes papers mainly focused on Review Articles and only one original article per issue in all fields of paediatrics including but not limited to the following fields: Adolescent Medicine, Developmental Pediatrics, and Medical genetics, Neonatology, Pediatric Allergology, Pediatric Cardiology, Pediatric Dermatology, Pediatric Endocrinology, Pediatric Gastroenterology, Pediatric Hematology and Oncology, Pediatric Infectious Diseases, Pediatric Intensive Care, Pediatric Nephrology, Pediatric Neurology, Pediatric Respirology, Pediatric Rheumatology, Pediatric Surgery.
Submission procedures
Manuscripts must be submitted only via online submission. Once you have prepared your manuscript according to the instructions below. Please visit the online submission web site. http://jpediatricsreview.com/en/index.html
Types of Articles
Journal of Pediatrics Review welcomes just the following types of submissions:
-
Review Articles including: Narrative Review, Systematic Review and Meta analysis
-
Case Report and Review of Literature
-
One Original Article per issue.
-
Letter to the Editor
-
Editorial
- Study Protocol
Manuscript preparation
Font type and size – To distinguish different parts of the article, it is recommended to use the Times New Roman font (size 12) for the body, size 12 bold for subheadings, size 14 bold for headings and size 14 bold for the title.
Page numbering – Number the pages consecutively, not included the title page. The last name of the first author should appear in the footer of each page (down right corner).
Abbreviations – Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Measurements – Authors should express all measurements in conventional units, with System International (SI) units given in parentheses throughout the text. Figures and tables should use conventional units, with conversion factors given in legends or footnotes. In accordance with the Uniform Requirements, however, manuscripts containing only SI units will not be returned for that reason.
Drug Names - Generic names should be used. When proprietary brands are used in research, include the brand name and the name of the manufacturer in parentheses after the first mention of the generic name in the Methods section.
Headings – Provide appropriate headings and subheading in the Abstract, main text for each type of manuscript based on specific order mentioned in the instruction for authors.
Word Count Limits
Research Articles: 3000 words without references (with a maximum of 60 references and 6 illustrations/tables)
Narrative Review Articles: 2500 - 4000 words without references (with a maximum of 80 references and 5 illustrations/tables)
Systematic Review Articles/ Meta-Analyses: 4000 words without references (with a maximum of 100 references and 6 illustrations/Tables)
Case Report and Review of Litrature: 2500 – 3000 words without references (with a maximum of 35 references and 2 illustrations/tables)
Letters to the Editor: 500 words without references (with a maximum of 10 references and 1 illustration/table)
Editorials: 1200 words without references (with a maximum of 10 references and 1 illustration/table)
Font type and size – To distinguish different parts of the article, it is recommended to use the Times New Roman font (size 12) for the body, size 12 bold for subheadings, size 14 bold for headings and size 14 bold for the title.
Page numbering – Number the pages consecutively, not included the title page. The last name of the first author should appear in the footer of each page (down right corner).
Abbreviations – Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.
Measurements – Authors should express all measurements in conventional units, with System International (SI) units given in parentheses throughout the text. Figures and tables should use conventional units, with conversion factors given in legends or footnotes. In accordance with the Uniform Requirements, however, manuscripts containing only SI units will not be returned for that reason.
Drug Names - Generic names should be used. When proprietary brands are used in research, include the brand name and the name of the manufacturer in parentheses after the first mention of the generic name in the Methods section.
Headings – Provide appropriate headings and subheading in the Abstract, main text for each type of manuscript based on specific order mentioned in the instruction for authors.
Word Count Limits
Research Articles: 3000 words without references (with a maximum of 60 references and 6 illustrations/tables)
Narrative Review Articles: 2500 - 4000 words without references (with a maximum of 80 references and 5 illustrations/tables)
Systematic Review Articles/ Meta-Analyses: 4000 words without references (with a maximum of 100 references and 6 illustrations/Tables)
Case Report and Review of Litrature: 2500 – 3000 words without references (with a maximum of 35 references and 2 illustrations/tables)
Letters to the Editor: 500 words without references (with a maximum of 10 references and 1 illustration/table)
Editorials: 1200 words without references (with a maximum of 10 references and 1 illustration/table)
-
Other Article's Materials:
-
Figure legends (including multiple figure parts): 55-75 words
-
Acknowledgments (not including research funding): 45-55 words
-
Full Word File without Title Page- Full-text of the manuscript must be a word file (.doc or .docx). This file must contain all parts of the manuscript including: Abstract, Article Body, Figures, Tables, Acknowledgments, Financial Disclosure, Appendices and all other supplements in the format of Microsoft Word. Please do not include title page in this file since this file will be sent to reviewers. Important note: If you are using equations in your manuscript, just use Math Type along with Microsoft Office Word 2003. Using docx format with Microsoft Equation Editor may cause in creation of distorted PDFs from submission.
Reply to Reviewers- Author(s) must reply to all reviewers' comments in a separate word file, point by point. It is suggested that author(s) write both questions (from reviewers) and their answers one by one. Then this reply file must be uploaded during submitting a revision.
Furthermore, author(s) are requested to upload revised word file with highlighted parts. It means that all changes of a word file must be highlighted.
Tables
At the time of submission, all Tables should be placed within the text of manuscript. Tables also must be called correctly using Table # or Tables #- ##, in which # is the Table number.
-
Each Table should have borders with normal style without any colored row or column.
-
The style of Table should be simple.
Figures
Figures must be submitted as separate files in submission process. Each figure needs a caption.
-
Authors should declare in the cover letter that all figures of their manuscripts are original, otherwise the original source of figures should be mentioned and reprint form must be uploaded in the attachments.
-
Scanned graph from other resources will not be accepted to publish.
-
All Figures should be in the form of encapsulated postscript (.eps), power point (ppt), portable document format (pdf), Photoshop (psd), TIF (.tiff), PNG (png) or JPG (.jpg).
-
The raw data of the charts should be uploaded in Microsoft excel format (MS Office 1997-2003)
-
Please scan all images in at least 300dpi. Most consumer scanners scan in sRGB by default. However, if you are using a high-end scanner then Adobe RGB is recommended for optimum color depth. Color space should be in RGB.
-
Image quality specification for Line art (an image composed of lines and text which does not contain tonal or shaded areas) has resolution of 900 dpi, hafltone (a continuous tone photograph which contains no text) with 300 dpi and combination of both should have 500 dpi of resolution.
-
We will NOT accept any images with resolution below 300 dpi.
More information about file specifications can be seen at: http://www.ncbi.nlm.nih.gov/pmc/about/PMC_Filespec.html#Image_File_Requirements
Cover Letter
This letter should be uploaded through online system as a word file. By an official letter corresponding author should introduce the manuscript briefly and state that:
The manuscript is original work ofauthor. All data, tables, figures, etc. used in the manuscript are prepared originally by authors, otherwise the sources are cited and reprint permission should be attached. The manuscript has not been and will not be published elsewhere or submitted elsewhere for publication.
Conflict of interest: To prevent the information on potential conflict of interest for authors from being overlooked or misplaced, mention this information in the cover letter.
Ethics of experimentation/Informed consent: The cover letter must include a statement declaring that the study complies with current ethical considerations. Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient included in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
How to write Manuscript Parts:
A. Title Page
Author(s) must write:complete title of the manuscript, full names of all the authors with their last affiliations (department or institution, university, city, country), address for correspondence with telephone numbers, e-mail, and Fax number.
These items must be written in "Title Page":
Manuscript Title:
Running Title:
Author(s): full name of all authors should be mentioned.
Method: [First Name] [Middle Name] [Last Name]
Example: Marek JanBrensht
Affiliation: Author's affiliation contains only department and universitynot author's degree or position.
Method: [name of department], [name of university], [city], [country]
Example: Molecular Biology Department, Maastricht University, Maastricht, the Netherlands
Corresponding author: one of the authors should be selected for possible correspondence before and after publication. His/her address, telephoneand fax numbers and email address should be written.
Method:
[Name of Recipient]
[Full Postal Address]
[Tel] Method: + [country code] [city code] [phone number]
[Fax] Method: + [country code] [city code] [phone number]
E-mail: [Email address]
Example:
Abraham Ranst
Petersbon Street 2c, 6432 GC, Hoensbroek, the Netherlands
Tel: +31 22 1234566
Fax: +31 22 1234566
E-mail: email
domina.com
Cover Letter
This letter should be uploaded through online system as a word file. By an official letter corresponding author should introduce the manuscript briefly and state that:
The manuscript is original work ofauthor. All data, tables, figures, etc. used in the manuscript are prepared originally by authors, otherwise the sources are cited and reprint permission should be attached. The manuscript has not been and will not be published elsewhere or submitted elsewhere for publication.
Conflict of interest: To prevent the information on potential conflict of interest for authors from being overlooked or misplaced, mention this information in the cover letter.
Ethics of experimentation/Informed consent: The cover letter must include a statement declaring that the study complies with current ethical considerations. Authors reporting experimental studies on human subjects must include a statement of assurance in the Materials and Methods section of the manuscript reading that: (1) informed consent was obtained from each patient included in the study and (2) the study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki as reflected in a priori approval by the institution's human research committee. In studies involving animal experimentation, provide assurance that all animals received humane care according to the criteria outlined in the "Guide for the Care and Use of Laboratory Animals" prepared by the National Academy of Sciences and published by the National Institutes of Health (NIH publication 86-23 revised 1985).
How to write Manuscript Parts:
A. Title Page
Author(s) must write:complete title of the manuscript, full names of all the authors with their last affiliations (department or institution, university, city, country), address for correspondence with telephone numbers, e-mail, and Fax number.
These items must be written in "Title Page":
Manuscript Title:
Running Title:
Author(s): full name of all authors should be mentioned.
Method: [First Name] [Middle Name] [Last Name]
Example: Marek JanBrensht
Affiliation: Author's affiliation contains only department and universitynot author's degree or position.
Method: [name of department], [name of university], [city], [country]
Example: Molecular Biology Department, Maastricht University, Maastricht, the Netherlands
Corresponding author: one of the authors should be selected for possible correspondence before and after publication. His/her address, telephoneand fax numbers and email address should be written.
Method:
[Name of Recipient]
[Full Postal Address]
[Tel] Method: + [country code] [city code] [phone number]
[Fax] Method: + [country code] [city code] [phone number]
E-mail: [Email address]
Example:
Abraham Ranst
Petersbon Street 2c, 6432 GC, Hoensbroek, the Netherlands
Tel: +31 22 1234566
Fax: +31 22 1234566
E-mail: email
domina.comB. Abstract and Keywords
[Required for: Review Articles, Case Reports and Review of Literature and Research Articles]
B.1. Abstract:
An abstract of 250-350 words should be provided to state the reason for the study, the main findings and the conclusions drawn from the observation.
An abstract of a Research Article known as Original article should be structured with the following headings: Background, Objectives, Methods, Results and Conclusions.
An abstract of a Narrative review should be included the following headings: Context, Evidence Acquisition,Resultsand Conclusions.
An abstract of a Systematic Review with or without Meta-Analysis in accordance with thePRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement should be subdivided into the following sequential sections: Context, Objective, Data Sources, Study Selection, Data Extraction, Results and Conclusions.
An abstract of a Case Report and Review of Literature should follow these headings: Introduction, Case Report or Case Presentations and Conclusions.
B.2. Keywords:
A list of 3-10 keywords must be provided for indexing purposes. All keywords should be provided according to the MeSH termsat: http://www.nlm.nih.gov/mesh/MBrowser.html. Note that the preferred expression is indicated by the label "MeSH Heading" and not "Entry Term." The desired terms may then be copied from the MeSH Browser. Another way of finding appropriate headings is to search PubMed to find articles on similar topics, and review the MeSH headings assigned to those articles. To read more about Keywords click here.
C. Article Body
[Required for: Research Articles, Review Articles, Case Reports and Review of litrature]
C.1.Research Articles
Research Articles also are called Original Articles, which are considered as the common types of articles. The content of the paper must justify its length. For the original research, traditional sections are required including: Introduction, Methods, Results, Discussion, conclusion, References, and Acknowledgements. The legends are required to illustrate Figures and Tables. Research articles should contain 2500 - 3000 words, with a maximum of 60 references, Maximum number of illustrations/Tables is 6.
C.2. Review Articles
C.2.A. Narrative Review: Body of a Narrative Review article should be included the following sections:
1. Context: In the body of manuscript, it is equal to introduction.
2. Evidence Acquisition: This section describes the data sources, including the research strategies, time of study, and other sources of the used materials, such as subsequent reference searches of retrieved articles. It explains the methods used for quality assessment and the inclusion of identified articles. In abstract this part is a brief form of the Evidence Acquisition.
3) Results: This section addresses the major findings and discusses the clinical issue or topic in an evidence-based, objective, and balanced style, emphasizing the available highest-quality evidences.
4) Conclusions: It clearly states the conclusions to answer the posed questions, if applicable, based on the conclusions of the available evidences, and it emphasizes how clinicians should apply the current knowledge.
- Narrative Review Article should contain 2500 - 3000 words without references, with a maximum of 80 references Maximum number of illustrations/ Tables is 7.
C.2.B. Systematic Review with or without Meta Analysis
Authors should report systematic reviews with or without meta-analyses in accordance with thePRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Systematic Reviews should be contained up to 4000 words without references, with a maximum of 100 references, and maximum number of illustrations/Tables is 10. For Systematic Reviews, the text of the manuscript should be subdivided into the following sequential sections:
1) Context: Provide a sentence or two explaining the importance of the review question.
2) Objective: State the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed.
3) Data Sources: Succinctly summarize data sources, including years searched. Include in the search the most current information possible, ideally conducting the search several months before the date of manuscript submission. Potential sources include computerized databases and published indexes, registries, abstract booklets, conference proceedings, references identified from bibliographies of pertinent articles and books, experts or research institutions active in the field, and companies or manufacturers of tests or agents being reviewed. If a bibliographic database is used, state the exact indexing terms used for article retrieval, including any constraints (for example, English language or human subjects). If abstract space does not permit this level of detail, summarize sources in the abstract including databases and years searched, and place the remainder of the information in the "Methods" section of the text.
4) Study Selection: Describe inclusion and exclusion criteria used to select studies for detailed review from among studies identified as relevant to the topic. Under details of selection include particular populations, interventions, outcomes, or methodological designs. Specify the method used to apply these criteria (for example, blinded review, consensus, multiple reviewers). State the proportion of initially identified studies that met selection criteria.
5) Data Extraction: Describe guidelines used for abstracting data and assessing data quality and validity (such as criteria for causal inference). State the method by which the guidelines were applied (eg, independent extraction by multiple observers).
6) Results: State the main results of the review, whether qualitative or quantitative, and outline the methods used to obtain these results. For meta-analyses, state the major outcomes that were pooled and include odds ratios or effect sizes and, if possible, sensitivity analyses. Accompany numerical results by confidence intervals, if applicable, and exact levels of statistical significance. For evaluations of screening and diagnostic tests, include sensitivity, specificity, likelihood ratios, receiver operating characteristic curves, and predictive values. For assessments of prognosis, summarize survival characteristics and related variables. State the major identified sources of variation between studies, including differences in treatment protocols, protocols, co-interventions, confounders, outcome measures, length of follow-up, and dropout rates.
7) Discussion: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
8) Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
Meta-analysis of observational studies: A MOOSE checklist is required for meta-analysis of observation studies (https://www.strobe-statement.org/index.php?id=available-checklists )
An abstract of 250-350 words should be provided to state the reason for the study, the main findings and the conclusions drawn from the observation.
An abstract of a Research Article known as Original article should be structured with the following headings: Background, Objectives, Methods, Results and Conclusions.
An abstract of a Narrative review should be included the following headings: Context, Evidence Acquisition,Resultsand Conclusions.
An abstract of a Systematic Review with or without Meta-Analysis in accordance with thePRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement should be subdivided into the following sequential sections: Context, Objective, Data Sources, Study Selection, Data Extraction, Results and Conclusions.
An abstract of a Case Report and Review of Literature should follow these headings: Introduction, Case Report or Case Presentations and Conclusions.
B.2. Keywords:
A list of 3-10 keywords must be provided for indexing purposes. All keywords should be provided according to the MeSH termsat: http://www.nlm.nih.gov/mesh/MBrowser.html. Note that the preferred expression is indicated by the label "MeSH Heading" and not "Entry Term." The desired terms may then be copied from the MeSH Browser. Another way of finding appropriate headings is to search PubMed to find articles on similar topics, and review the MeSH headings assigned to those articles. To read more about Keywords click here.
C. Article Body
[Required for: Research Articles, Review Articles, Case Reports and Review of litrature]
C.1.Research Articles
Research Articles also are called Original Articles, which are considered as the common types of articles. The content of the paper must justify its length. For the original research, traditional sections are required including: Introduction, Methods, Results, Discussion, conclusion, References, and Acknowledgements. The legends are required to illustrate Figures and Tables. Research articles should contain 2500 - 3000 words, with a maximum of 60 references, Maximum number of illustrations/Tables is 6.
C.2. Review Articles
C.2.A. Narrative Review: Body of a Narrative Review article should be included the following sections:
1. Context: In the body of manuscript, it is equal to introduction.
2. Evidence Acquisition: This section describes the data sources, including the research strategies, time of study, and other sources of the used materials, such as subsequent reference searches of retrieved articles. It explains the methods used for quality assessment and the inclusion of identified articles. In abstract this part is a brief form of the Evidence Acquisition.
3) Results: This section addresses the major findings and discusses the clinical issue or topic in an evidence-based, objective, and balanced style, emphasizing the available highest-quality evidences.
4) Conclusions: It clearly states the conclusions to answer the posed questions, if applicable, based on the conclusions of the available evidences, and it emphasizes how clinicians should apply the current knowledge.
- Narrative Review Article should contain 2500 - 3000 words without references, with a maximum of 80 references Maximum number of illustrations/ Tables is 7.
C.2.B. Systematic Review with or without Meta Analysis
Authors should report systematic reviews with or without meta-analyses in accordance with thePRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) statement. Systematic Reviews should be contained up to 4000 words without references, with a maximum of 100 references, and maximum number of illustrations/Tables is 10. For Systematic Reviews, the text of the manuscript should be subdivided into the following sequential sections:
1) Context: Provide a sentence or two explaining the importance of the review question.
2) Objective: State the precise primary objective of the review. Indicate whether the review emphasizes factors such as cause, diagnosis, prognosis, therapy, or prevention and include information about the specific population, intervention, exposure, and tests or outcomes that are being reviewed.
3) Data Sources: Succinctly summarize data sources, including years searched. Include in the search the most current information possible, ideally conducting the search several months before the date of manuscript submission. Potential sources include computerized databases and published indexes, registries, abstract booklets, conference proceedings, references identified from bibliographies of pertinent articles and books, experts or research institutions active in the field, and companies or manufacturers of tests or agents being reviewed. If a bibliographic database is used, state the exact indexing terms used for article retrieval, including any constraints (for example, English language or human subjects). If abstract space does not permit this level of detail, summarize sources in the abstract including databases and years searched, and place the remainder of the information in the "Methods" section of the text.
4) Study Selection: Describe inclusion and exclusion criteria used to select studies for detailed review from among studies identified as relevant to the topic. Under details of selection include particular populations, interventions, outcomes, or methodological designs. Specify the method used to apply these criteria (for example, blinded review, consensus, multiple reviewers). State the proportion of initially identified studies that met selection criteria.
5) Data Extraction: Describe guidelines used for abstracting data and assessing data quality and validity (such as criteria for causal inference). State the method by which the guidelines were applied (eg, independent extraction by multiple observers).
6) Results: State the main results of the review, whether qualitative or quantitative, and outline the methods used to obtain these results. For meta-analyses, state the major outcomes that were pooled and include odds ratios or effect sizes and, if possible, sensitivity analyses. Accompany numerical results by confidence intervals, if applicable, and exact levels of statistical significance. For evaluations of screening and diagnostic tests, include sensitivity, specificity, likelihood ratios, receiver operating characteristic curves, and predictive values. For assessments of prognosis, summarize survival characteristics and related variables. State the major identified sources of variation between studies, including differences in treatment protocols, protocols, co-interventions, confounders, outcome measures, length of follow-up, and dropout rates.
7) Discussion: Summarize the main findings including the strength of evidence for each main outcome; consider their relevance to key groups (e.g., healthcare providers, users, and policy makers). Discuss limitations at study and outcome level (e.g., risk of bias), and at review-level (e.g., incomplete retrieval of identified research, reporting bias).
8) Conclusions: Provide a general interpretation of the results in the context of other evidence, and implications for future research.
Meta-analysis of observational studies: A MOOSE checklist is required for meta-analysis of observation studies (https://www.strobe-statement.org/index.php?id=available-checklists )
C.1.D. Case Report and Review of Literature
The body of Case reports and review of Literature should comprise sections including Introduction, Case Presentation, Discussion and Review of Literature in the text and Conclusions with no more than 2 tables or figures and up to 35 references. Case reports should contain 2500 – 3000 words without references.
D. Study Protocol
For a Study Protocol, based on the format of Cochrane Protocols, it should be subdivided into the following sequential sections: HEADER, ABSTRACT, BACKGROUND, OBJECTIVES, METHODS, ACKNOWLEDGEMENTS, REFERENCES, APPENDICES, CONTRIBUTIONS OF AUTHORS, and DECLARATIONS OF INTEREST.
Acknowledgments
All contributors who do not meet the criteria for authorship should be covered in theacknowledgement section. It should include persons who provided technical help, writing assistance and departmental head that only provided general support. Financial and material support should also be acknowledged.
Conflict of Interest Disclosure
Conflict of Interests must be included in the cover letter to prevent overlooked or misplaced information on potential conflict of interests. Authors must identify any potential financial conflict of interests before the review process begins. Declared conflict of interest will not automatically result in rejection of a paper but the editors reserve the right to publish any declared conflict of interest alongside the acceptance. The following statements would generally be regarded aspotential conflict of interests:
1. Direct financial payment to an author for the research or manuscript production by the sponsor of a product or service evaluated in an article.
2. Ownership of shares by an author in the company sponsoring a product service evaluated in an article (or in a company sponsoring a competing product).
3. Personal consultant for companies or other organizations with a financial interest forpromotion of particular health care products and services.
Financial Disclosure
Should apply for all manuscript submissions, including letters to the editor, opinion pieces, informal essays, and book reviews. Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future. Many universities and other institutions and organizations have established policies and thresholds for reporting financial interests andother conflict of interests. Authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript.
Example: Dr de Lemos reported receiving research grants and honoraria and consulting fees for speaking from Biosite and Roche. Dr Blazing reported receiving honoraria from Merck and Pfizer.
Funding/Support
Detailed information regarding all financial and material support for the research and work.
It must not be limited to grant support, funding sources, and provision of equipment and supplies.
Example: This study was supported in part by grant CA34988 from the National Institutes of Health and by a teaching and research scholarship from the American College of Physicians (DrFischl).
Authors' Contribution
Authors are asked to describe their contribution in the study, and these contributions to the work may be published at the editor's discretion.
Example: Author Contributions: Study concept and design: Fortes, Melchi, and Abeni. Analysis and interpretation of data: Fortes, Mastroeni, and Leffondre. Drafting of the manuscript: Fortes. Critical revision of the manuscript for important intellectual content: Mastroeni, Leffondre, Sampogna, Melchi, Mazzotti, Pasquini, and Abeni. Statistical analysis: Fortes and Mastoeni.
Example: Yoon Kong Loke developed the original idea and the protocol, abstracted and analyzed data, wrote the manuscript, and isguarantor. Deirdre Price and Sheena Derry contributed to the development of the protocol, abstracted data, and prepared the manuscript.
How to write?
Please clarify and write who was responsible for:
-
Study concept and design:
-
Acquisition of data:
-
Analysis and interpretation of data:
-
Drafting of the manuscript:
-
Critical revision of the manuscript for important intellectual content:
-
Statistical analysis:
-
Administrative, technical, and material support:
-
Study supervision:
References
This Journal accepts references according to the Vancouver style. For Journal of Pediatrics Review, in the Vancouver system, the numbers are the only indication required in the text, allocated in ascending sequence, and presented in the text in the Parenthesis and before punctuation.
For example:
"Recent randomized controlled trials in primary care showed benefits for patients with depression from increased telephone support, better cooperation between primary care and mental health professionals, and more systematic follow up (7)."
a. Anonymous Books and Articles
If you can't access the author(s) for a book or an article to cite, begin the entry with the title. Do not use either "Anonymous" or "anon". A sample is provided below:
Example: Health and Dictatorship: Effects of Repression in Turkmenistan. Lancet. 2003 Jan 4; 361(9351):69-70.
b. Conference Papers
You may wish to cite a paper or collection of papers presented at a conference or seminar. These are generally known as conference papers or proceedings. Below, you can find the details needed to construct a reference for a conference paper. The punctuation marks at the end of each element are those you should use.
This Journal accepts references according to the Vancouver style. For Journal of Pediatrics Review, in the Vancouver system, the numbers are the only indication required in the text, allocated in ascending sequence, and presented in the text in the Parenthesis and before punctuation.
For example:
"Recent randomized controlled trials in primary care showed benefits for patients with depression from increased telephone support, better cooperation between primary care and mental health professionals, and more systematic follow up (7)."
a. Anonymous Books and Articles
If you can't access the author(s) for a book or an article to cite, begin the entry with the title. Do not use either "Anonymous" or "anon". A sample is provided below:
Example: Health and Dictatorship: Effects of Repression in Turkmenistan. Lancet. 2003 Jan 4; 361(9351):69-70.
b. Conference Papers
You may wish to cite a paper or collection of papers presented at a conference or seminar. These are generally known as conference papers or proceedings. Below, you can find the details needed to construct a reference for a conference paper. The punctuation marks at the end of each element are those you should use.
-
Author's or authors' surname(s) followed by first name or initials.
-
Title of the paper.
-
In: (to indicate that the next element is the collection of papers from the conference)
-
Editor's or editors' surname (s) followed by initials or first name if the paper appears in an edited book.
-
Title of the conference;
-
Date of conference;
-
Place of publication:
-
Publisher's name;
-
Year of publication.
-
Page numbers.
For example: Anderson JC. Current Status of Chorion Villus Biopsy. In: Tudenhope D, Chenoweth J, editors. Proceedings of the Fourth Congress of the Australian Perinatal Society; 1986 Sept. 3-6; Brisbane, Queensland: Australian Perinatal Society; 1987. p. 190-6.
c. Corporate Publications
Reports which are not the responsibility of one individual should be listed under the name of the body, responsible for their publication.
Note: corporate publications should not be listed under the name of the chairman of a committee, in spite of the fact that they are commonly referred to in this way.
Example: The Royal Marsden Hospital Bone-Marrow Transplantation Team. Failure of Syngeneic Bone-Marrow Graft without Preconditioning in Post-Hepatitis Marrow Aplasia. Lancet 1977; 2:242-4.
d. Journal Articles
Standard journal article
List the first six authors followed by et al. (Note: NLM now lists all authors.)
--Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, et al.Vitamin E and Respiratory TractI infections in Elderly Nursing Home Residents: a Randomized Controlled Trial. JAMA. 2004 Aug 18;292(7):828-36.
--Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.
--As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted.
--Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
More than six authors
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.
Optional addition of a database's unique identifier for the citation
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7. PubMed PMID: 12140307.
Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveiticfoveal atrophy: clinical features and associations. Arch Ophthalmol. 2009 Feb;127(2):179-86. PubMed PMID: 19204236; PubMed Central PMCID: PMC2653214.
Optional addition of a clinical trial registration number
Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.
Organization as the author
Diabetes Prevention Program Research Group.Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.Hypertension. 2002;40(5):679-86.
Both personal authors and organization as the author (List all as they appear in the byline.)
-- Vallancien G, Emberton M,Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.
-- Margulies EH, Blanchette M; NISC Comparative Sequencing Program, Haussler D, Green ED. Identification and characterization of multi-species conserved sequences. Genome Res. 2003 Dec;13(12):2507-18.
No author is given
21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.
Article not in English
Ellingsen AE, Wilhelmsen I. Sykdomsangstblantmedisin-ogjusstudenter. TidsskrNorLaegeforen. 2002;122(8):785-7. Norwegian.
Optional translation of the article title
Ellingsen AE, Wilhelmsen I. [Disease anxiety among medical students and law students]. TidsskrNorLaegeforen. 2002 Mar 20;122(8):785-7. Norwegian.
Volumewith the supplement
Geraud G, Spierings EL, Keywood C. Tolerability and safety offrovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42Suppl 2:S93-9.
Issue with the supplement
Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002; 58(12 Suppl 7):S6-12.
Volume with the part
Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002; 83(Pt 2):491-5.
Issue with the part
Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.
Issue with no volume:
Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty.ClinOrthop. 2002;(401):230-8.
No volume or issue:
Outreach: bringing HIV-positive individuals into care. HRSA Care action. 2002 Jun:1-6.
Pagination in roman numerals
Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002; 16(2):iii-v.
The type of article is indicated as needed
-- Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002; 20(1):242.
-- Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002; 66 Suppl 1:S105.
Article containing a retraction
Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.J Clin Psychiatry. 2002; 63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000; 61(12):909-11.
Article containing a partial retraction
Starkman JS,Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. J Urol. 2006 Dec;176(6 Pt 1):2749. Partial retraction of: Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Sep; 176(3):1040-4.
Article retracted
Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000; 61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002; 63(2):169.
Article partially retracted
Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction following removal of erodedsyntheticmid urethral slings. J Urol. 2006 Sep; 176(3):1040-4. Partial retraction in: Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Dec; 176(6 Pt 1):2749.
Article republished with corrections
Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002; 188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001; 183(1-2):123-6.
Article with published erratum
Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.ClinTher. 2000; 22(10):1151-68; discussion 1149-50. Erratum in: ClinTher. 2001; 23(2):309.
Article published electronically ahead of the print version
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15; 100(10):3828-31. Epub 2002 Jul 5.
e. Online Sources
For all websites, the access date (date of access to the information) and the database name or web address (URL) are needed. You can cite online articles in the same way you would print.
c. Corporate Publications
Reports which are not the responsibility of one individual should be listed under the name of the body, responsible for their publication.
Note: corporate publications should not be listed under the name of the chairman of a committee, in spite of the fact that they are commonly referred to in this way.
Example: The Royal Marsden Hospital Bone-Marrow Transplantation Team. Failure of Syngeneic Bone-Marrow Graft without Preconditioning in Post-Hepatitis Marrow Aplasia. Lancet 1977; 2:242-4.
d. Journal Articles
Standard journal article
List the first six authors followed by et al. (Note: NLM now lists all authors.)
--Meydani SN, Leka LS, Fine BC, Dallal GE, Keusch GT, Singh MF, et al.Vitamin E and Respiratory TractI infections in Elderly Nursing Home Residents: a Randomized Controlled Trial. JAMA. 2004 Aug 18;292(7):828-36.
--Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7.
--As an option, if a journal carries continuous pagination throughout a volume (as many medical journals do) the month and issue number may be omitted.
--Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002;347:284-7.
More than six authors
Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.
Optional addition of a database's unique identifier for the citation
Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med. 2002 Jul 25;347(4):284-7. PubMed PMID: 12140307.
Forooghian F, Yeh S, Faia LJ, Nussenblatt RB. Uveiticfoveal atrophy: clinical features and associations. Arch Ophthalmol. 2009 Feb;127(2):179-86. PubMed PMID: 19204236; PubMed Central PMCID: PMC2653214.
Optional addition of a clinical trial registration number
Trachtenberg F, Maserejian NN, Soncini JA, Hayes C, Tavares M. Does fluoride in compomers prevent future caries in children? J Dent Res. 2009 Mar;88(3):276-9. PubMed PMID: 19329464. ClinicalTrials.gov registration number: NCT00065988.
Organization as the author
Diabetes Prevention Program Research Group.Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.Hypertension. 2002;40(5):679-86.
Both personal authors and organization as the author (List all as they appear in the byline.)
-- Vallancien G, Emberton M,Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.
-- Margulies EH, Blanchette M; NISC Comparative Sequencing Program, Haussler D, Green ED. Identification and characterization of multi-species conserved sequences. Genome Res. 2003 Dec;13(12):2507-18.
No author is given
21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.
Article not in English
Ellingsen AE, Wilhelmsen I. Sykdomsangstblantmedisin-ogjusstudenter. TidsskrNorLaegeforen. 2002;122(8):785-7. Norwegian.
Optional translation of the article title
Ellingsen AE, Wilhelmsen I. [Disease anxiety among medical students and law students]. TidsskrNorLaegeforen. 2002 Mar 20;122(8):785-7. Norwegian.
Volumewith the supplement
Geraud G, Spierings EL, Keywood C. Tolerability and safety offrovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42Suppl 2:S93-9.
Issue with the supplement
Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002; 58(12 Suppl 7):S6-12.
Volume with the part
Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002; 83(Pt 2):491-5.
Issue with the part
Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.
Issue with no volume:
Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty.ClinOrthop. 2002;(401):230-8.
No volume or issue:
Outreach: bringing HIV-positive individuals into care. HRSA Care action. 2002 Jun:1-6.
Pagination in roman numerals
Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002; 16(2):iii-v.
The type of article is indicated as needed
-- Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002; 20(1):242.
-- Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002; 66 Suppl 1:S105.
Article containing a retraction
Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone.J Clin Psychiatry. 2002; 63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000; 61(12):909-11.
Article containing a partial retraction
Starkman JS,Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction after removal of eroded slings. J Urol. 2006 Dec;176(6 Pt 1):2749. Partial retraction of: Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Sep; 176(3):1040-4.
Article retracted
Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000; 61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002; 63(2):169.
Article partially retracted
Starkman JS, Wolter C, Gomelsky A, Scarpero HM, Dmochowski RR. Voiding dysfunction following removal of erodedsyntheticmid urethral slings. J Urol. 2006 Sep; 176(3):1040-4. Partial retraction in: Starkman JS, Wolder CE, Gomelsky A, Scarpero HM, Dmochowski RR. J Urol. 2006 Dec; 176(6 Pt 1):2749.
Article republished with corrections
Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002; 188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001; 183(1-2):123-6.
Article with published erratum
Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review.ClinTher. 2000; 22(10):1151-68; discussion 1149-50. Erratum in: ClinTher. 2001; 23(2):309.
Article published electronically ahead of the print version
Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15; 100(10):3828-31. Epub 2002 Jul 5.
e. Online Sources
For all websites, the access date (date of access to the information) and the database name or web address (URL) are needed. You can cite online articles in the same way you would print.
-
WWW document
These are the details you need to cite a web document:
Author/editor's surname author/editor's first name or initials. Editor [if appropriate]. Title of page. Titleof
-
site. Last update or copyright date. URL (Access date).
Below is a sample reference for a web document.
Royal College of General Practitioners. The Primary Health Care Team. RCGP website 2003 [cited 2004 Sep 22]; Available from: URL: http://www.rcgp.org.uk/information/publications/information/PDFInfo/21_OCT_03.pdf -
Article in an online format
These are the details you need:
Author's surname, initials. (Year) Document title. Journal title, Volume (part).
Below is a sample reference for an online article.
Drasin, Todd, Dutson, Erik and Gracia, Carlos. Use of a Robotic System as Surgical First Assistant in Advanced Laparoscopic Surgery. Journal of the American College of Surgeons, 199(3).
f. Other Published Materials
Other published materials (other than what mentioned in other pages of the help) should be cited as below:
-
Newspaper article
-
Example: Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).
-
-
Audiovisual material
-
Example: Chason KW, Sallustio S. Hospital preparedness for bioterrorism [videocassette]. Secaucus (NJ): Network for Continuing Medical Education; 2002.
-
-
Legal Material
-
Public law
-
Example: Veterans Hearing Loss Compensation Act of 2002, Pub. L. No. 107-9, 115 Stat. 11 (May 24, 2001).
-
-
Unenacted bill
-
Example: Healthy Children Learn Act, S. 1012, 107th Cong., 1st Sess. (2001).
-
-
Code of Federal Regulations:
-
Example: Cardiopulmonary Bypass Intracardiac Suction Control, 21 C.F.R. Sect. 870.4430 (2002).
-
-
Hearing
-
Example: Arsenic in Drinking Water: An Update on the Science, Benefits and Cost: Hearing Before the Subcomm. On Environment, Technology and Standards of the House Comm. on Science, 107th Cong., 1st Sess. (Oct. 4, 2001).
-
-
-
Map
-
Example: Pratt B, Flick P, Vynne C, cartographers. Biodiversity hotspots [map]. Washington: Conservation International; 2000.
-
-
Dictionary and similar references
-
Example: Dorland's illustrated medical dictionary. 29th ed. Philadelphia: W.B. Saunders; 2000. Filamin; p. 675.
-
g.Unpublished Materials (Accepted)
In order to cite an unpublished, in press or forthcoming material, the following method is recommended:
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. ProcNatlAcadSci U S A. Forthcoming 2002.
Note: NLM prefers "Forthcoming" rather than "In press" because not all items will be printed.
Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. ProcNatlAcadSci U S A. Forthcoming 2002.
Note: NLM prefers "Forthcoming" rather than "In press" because not all items will be printed.
Ethical guidelines
When reporting experiments on human subjects, indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html). Do not use patients' names, initials, or hospital numbers, especially in illustrative material. When reporting experiments on animals, indicate whether the institutions or a national research council's guide for, or any national law on the care and use of laboratory animals was followed. It is mandatory to mention the University/ Institutional ethical clearance registration number in the methodology section.
Publication Ethics
Ethical standards for publication exist to ensure high-quality scientific publications, public trust in scientific findings, and that people receive credit for their ideas. Journal of Pediatrics Review published by Mazandaran University of Medical Sciences is committed to publishing review articles; Systematic review with or without Meta-analysis, Narrative review, Case Report and Review the literatures and Letters to the Editor. So, it is important to avoid the following ethical violations.
Data Fabrication and Falsification
Data fabrication and falsification means the researcher did not actually do the study, but made up data or results and had recorded or reported the fabricated information. Data falsification means the researcher did the experiment, but manipulated, changed, or omitted data or results from the research findings. This would lead to public distrust and less willing to provide funding support.
Plagiarism
Plagiarism is deliberately using someone else’s language, ideas, or other original material without acknowledging its source and without giving them credit. Copying even one sentence from someone else’s manuscript, or even one of your own that has previously been published, without proper citation is considered plagiarism-use your own words instead.
Simultaneous Submission
Simultaneous submission occurs when a manuscript (or substantial sections from a manuscript) is submitted to a journal when it is already under consideration by another journal.
Duplicate Publication
Duplicate publication occurs when two or more papers, without full cross referencing, share essentially the same hypotheses, data, discussion points, and conclusions.
Redundant Publications
Redundant publications involve the inappropriate division of study outcomes into several articles, most often consequent to the desire to plump academic vitae.
Improper Author Contribution or Attribution
All listed authors must have made a significant scientific contribution to the research in the manuscript and approved all its claims. Don’t forget to list everyone who made a significant scientific contribution, including students and laboratory technicians.
Citation Manipulation
Citation Manipulation is including excessive citations, in the submitted manuscript, that do not contribute to the scholarly content of the article and have been included solely for the purpose of increasing citations to a given author’s work, or to articles published in a particular journal. This leads to misrepresenting the importance of the specific work and journal in which it appears and is thus a form of scientific misconduct. In the event that there are documented violations of any of the above mentioned policies in any journal, immediate rejection of the infringing manuscript will be applied.
Assurances
In appropriate places in the manuscript, please provide the following items:
If applicable, a statement that the research protocol was approved by the relevant institutional review boards or ethics committees and that all human participants gave written informed consent.
The identity of those who analyzed the data.
For studies containing microarrays, the accession numbers and repository name.
Copyright
JPR is fully compliant with open access mandates, by publishing its articles under the Creative Commons Attribution-NonCommercial license (CC-BY-NC). Authors retain the copyright of their work and can deposit their publication in any repository. This means that articles can be freely redistributed and reused by the author and others as long as the article is properly cited. Published articles can be deposited immediately into an online repository or social network without any cost. Articles can be emailed to colleagues, printed, archived in a collection, included in course-packs, and distributed without restrictions. Please read the full Creative Commons license for further information.
Article Processing Charges
Mazandaran University of Medical Sciences has supported part of the publishing costs of the Journal of Pediatrics Review, article processing charges in the journal are limited to authors. Therefore, publishing an article in the Journal requires a publication fee that will be paid by the corresponding author following the acceptance of an article for publication, applied since June 2020. Apart from this Publication fee, the journal provides a Fast Track option for the authors. Fast reviewing and decision about the paper is the benefit of this option. The fee for Fast Track Publication is stated below.
Apart from this Article Process Charges, there are no submission charges, page charges, or color charges. The fees to be paid following the acceptance of an article are indicated in the table below:
Article Processing Charges
Mazandaran University of Medical Sciences has supported part of the publishing costs of the Journal of Pediatrics Review, article processing charges in the journal are limited to authors. Therefore, publishing an article in the Journal requires a publication fee that will be paid by the corresponding author following the acceptance of an article for publication, applied since June 2020. Apart from this Publication fee, the journal provides a Fast Track option for the authors. Fast reviewing and decision about the paper is the benefit of this option. The fee for Fast Track Publication is stated below.
Apart from this Article Process Charges, there are no submission charges, page charges, or color charges. The fees to be paid following the acceptance of an article are indicated in the table below:
| Paper Format | Fee | Reviewing Format |
|---|---|---|
| Original and Review articles (Non-Iranian Authors) | 50 US$ | Normal |
| Review articles (Iranian Authors) | 6,000,000 IR Rial (50% off for Mazandaran University of Medical Sciences Faculties) |
Normal |
| Original articles (Iranian Authors) | 12,000,000 IR Rial (50% off for Mazandaran University of Medical Sciences Faculties) |
Normal |
| Original and Review articles (Non-Iranian Authors) | 100 US$ | Fast Track |
| Review articles (Iranian Authors) | 12,000,000 IR Rial (50% off for Mazandaran University of Medical Sciences Faculties) |
Fast Track |
| Original articles (Iranian Authors) | 24,000,000 IR Rial (50% off for Mazandaran University of Medical Sciences Faculties) |
Fast Track |
View: 33947 Time(s) |
Print: 2682 Time(s) |
Email: 96 Time(s) |
0 Comment(s)
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC),
which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
